Hydroxychloroquine early in pregnancy and risk of birth defects: don't throw out the baby with the bathwater

Bonnie L. Bermas; Christina Chambers

doi:10.1016/j.ajog.2020.12.1218

Hydroxychloroquine early in pregnancy and risk of birth defects: don't throw out the baby with the bathwater

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	548-549
Number of pages	2
Journal	American journal of obstetrics and gynecology
Volume	224
Issue number	5
DOIs	https://doi.org/10.1016/j.ajog.2020.12.1218
State	Published - May 2021

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/j.ajog.2020.12.1218

Cite this

@article{e4e5c16720cf4653a41a584916c207d4,

title = "Hydroxychloroquine early in pregnancy and risk of birth defects: don't throw out the baby with the bathwater",

author = "Bermas, {Bonnie L.} and Christina Chambers",

note = "Funding Information: C.C. receives research funding from the following industry sponsors and a foundation: Amgen Inc; AstraZeneca; Celgene; GlaxoSmithKline; Janssen Pharmaceuticals, Inc; Pfizer Inc; Regeneron Pharmaceuticals Inc; Hoffmann-La Roche-Genentech; Genzyme Sanofi-Aventis; Takeda Pharmaceutical Company Limited; Sanofi; UCB Pharma, Smyrna, GA; Sun Pharma Global FZE; and the Gerber Foundation. ",

year = "2021",

month = may,

doi = "10.1016/j.ajog.2020.12.1218",

language = "English (US)",

volume = "224",

pages = "548--549",

journal = "American journal of obstetrics and gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Hydroxychloroquine early in pregnancy and risk of birth defects

T2 - don't throw out the baby with the bathwater

AU - Bermas, Bonnie L.

AU - Chambers, Christina

N1 - Funding Information: C.C. receives research funding from the following industry sponsors and a foundation: Amgen Inc; AstraZeneca; Celgene; GlaxoSmithKline; Janssen Pharmaceuticals, Inc; Pfizer Inc; Regeneron Pharmaceuticals Inc; Hoffmann-La Roche-Genentech; Genzyme Sanofi-Aventis; Takeda Pharmaceutical Company Limited; Sanofi; UCB Pharma, Smyrna, GA; Sun Pharma Global FZE; and the Gerber Foundation.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85100807814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100807814&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2020.12.1218

DO - 10.1016/j.ajog.2020.12.1218

M3 - Letter

C2 - 33434555

AN - SCOPUS:85100807814

SN - 0002-9378

VL - 224

SP - 548

EP - 549

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

IS - 5

ER -

Hydroxychloroquine early in pregnancy and risk of birth defects: don't throw out the baby with the bathwater

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this